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Analysis of the inheritance of mouse mammary tumor virus (MMTV) t expression 
in mice has originated  the concept that this virus can be genetically transmitted, as 
a chromosomal provirus (1). 
In  the  mouse  strain  GR,  a  single  dominant  gene  was  responsible  for  a  high 
expression  of MMTV  in  the milk,  and  for  the  development  of early  pregnancy- 
dependent  mammary tumors  (1-4).  The virus could be transmitted  by the male as 
well as by the female. This gene, Mtv-2, has recently been mapped on chromosome 
18,  linked  to  the  Tw  (Twirler)  locus.  (R.  Van  Nie.  Unpublished  observations.) 
However, other investigators disagreed with a single gene model. Nandi and Helmich 
(5)  reported that segregation of MMTV  expression in crosses between GR and low 
mammary tumor strains was under control of two genes and Heston and Parks (6,  7) 
found that the development of mammary tumors and virus expression were transmit- 
ted as a  multifactorial genetic trait. 
Molecular  biological  studies  showed  that  the  number of MMTV  proviral  DNA 
copies in the GR strain exceeds that of other strains (8, 9). A subset of these proviruses 
was proven to be identical to Mtv-2 the induction gene for high amounts of virus (8), 
Assuming  that  the  remaining  proviral  DNA  copies  could  also  give  rise  to  virus 
expression, it became well possible that the total MMTV expression in the GR strain 
was controlled by several genes. In such a model the Mtv-2 locus should be responsible 
for high amounts of virus expression and early mammary tumors whereas other loci, 
probably also identical to proviral DNA copies, should induce lower amounts of virus, 
only detectable with sensitive techniques such as a radioimmunoassay (10). 
The development of a  GR/Mtv-2- substrain, congenic to the GR but  lacking the 
Mtv-2 gene for high virus expression and early mammary tumors (I 1), provided the 
possibility to study the genetic control over MMTV expression that is not controlled 
by the  Mtv-2  gene.  This report  deals  with  the  analysis  and  location  of a  gene  for 
partial MMTV expression in the GR/Mtv-2- strain. 
* Supported in part by NOI-CP-33368. 
Supported by the Queen Wilhelmina Foundation. 
1 Abbreviations used in this paper: BCI, BCII, first and second backcross populations; BSA, bovine serum 
albumin; MMTV, mouse mammary tumor virus; mRNA, messenger  RNA, RIA radioimmunoassay;  TNE, 
10 mM Tris-HCl, pH 7.5, I mM EDTA, I00 mM NaCI. 
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Materials  and  Methods 
Mice.  BALB/c mice (BALB/c/HeA) and GR/Mtv-2- mice were'from the breeding colony 
of The Netherlands Cancer Institute, Amsterdam. The GR/Mtv-2- strain (11) is in the eighth 
inbred generation. 
Backcross Analysis.  The first backcross population (BCI) consisted of female progeny mice 
from  a  [2  (BALB/c  ×  GR/Mtv-2-)  ×  c~BALB/c]  cross.  These  mice  were  mated  again  to 
BALB/c males, generating a  second backcross (BCII) population. The first litter BCII mice 
were grown up and then the mothers, the BCI population, were sacrificed at the next lactation 
period. BCII females were also sacrificed at the second lactation. 
Preparation of Mammary Gland Extracts.  Mammary glands were minced, suspended in 10 mM 
Tris-HCl, pH 9.2,  1 mM EDTA, 400 mM KCI,  1% (vol/vol) Triton X-100 and disrupted by 
douncing combined with freeze-thawing. The homogenate was incubated for 20 min at 37°C 
and centrifuged for  10 min at 27,000 g. The supernate was dialyzed against TNE buffer (10 
mM Tris-HCI pH 7.5,  1 mM EDTA,  100 mM NaCI) with 0.4%  (vol/vol) Triton X-100. The 
dialyzed extracts were centrifuged for  1 h  at 30,000 g and total protein concentration in the 
supernate was measured using bovine serum albumin (BSA) as a standard (12). 
Labeling of Viral Proteins.  MMTV gp52 and p27 were isolated as previously described (13, 
14). The MMTV gag protein pl0 was isolated by means of phosphocellulose chromatography. 
The  envelope  protein  gp36  was  kindly  provided  by  Dr.  F.  Westenbrink,  Rijswijk,  The 
Netherlands (15). 
MMTV proteins were labeled with 125iodine according to Hunter and Greenwood (16). The 
final reaction mixture was composed of 15 ktl protein in TNE buffer (0.5 mg/ml), 25/xl 0.5 M 
NaHPO4  pH  7.4,  10 pl x2~iodine (Amersham Corp., Arlington Heights, Ill., carrier free,  100 
mCi/ml in NaOH pH 9-11), and  10 pl chloramine T  (1  mg/ml). Incubation was for 1 min at 
room temperature after which 5 ~1 Na2S20~  (10 mg/ml), and 50/xl 0.1  M  NaJ were added to 
stop  the  reaction.  Unbound  iodine was  removed  from  protein  on  a  Sephadex  G-50  (fine) 
column. Specific activities of labeled proteins ranged from 20,000-50,000 cpm/ng protein. The 
polyvalent rabbit anti-MMTV serum precipitated all four viral proteins at dilutions ranging 
from  1/5,000-1/20,000  (17). 
Radioimmunoassay.  Total protein concentration of tissue extracts was adjusted to 10 mg tissue 
protein per ml. Samples were serially diluted in 0.1 ml TNE buffer supplemented with 2 mg/ 
ml BSA and 0.2%  (vol/vol) Triton X-100.  10 pl of diluted anti-MMTV serum was added to 
each sample and incubated for 1 h at 37°C. Then, 40 btl of labeled protein (1 ng, 20,000-40,000 
cpm) diluted in normal rabbit serum was added. After a  3-h incubation at 37°C,  a  titrated 
amount goat anti-rabbit gamma globulin serum was added. Immune complexes were allowed 
to form overnight at 4°C, collected by centrifugation (10 min, 3,000 g), washed three times in 
cold TNE buffer, and counted. 
Electrophoretic mobility of Es-3  was examined according to published procedures (18). Briefly: 
hemolysates of erythrocytes were run on a  12% vertical starch gel in a Tris-EDTA-Borate buffer 
pH 3.6 and stained with 1 mg/ml 4 methylum umbelliferone propionate in a 0.1 M  Na citrate 
buffer, pH 5.5. The solutions were applied on a filter paper overlays. After 15 min the gel could 
be scored for Es-3 under a long-wave UV lamp. 
Results 
Expression of the  MMTV  Genome in  the  GR/Mtv-2-  Strain.  MMTV  contains  six 
structural proteins that are encoded on the viral genome, the envelope proteins gp52 
and  gp36,  and  the core proteins p27,  p21,  p14,  and  pl0.  Synthesis of envelope and 
core proteins proceeds independently from each other. The core, or gag, proteins are 
synthesized from a  35S messenger RNA (mRNA), initially as a  precursor polypeptide 
of  73,000  dalton  (16,  19).  A  24S  mRNA  instructs  synthesis  of envelope,  or  env, 
proteins,  also  via  a  precursor  polyprotein  of  73,000  dalton  (20).  To  measure  the 
expression  of individual representative  genes  of MMTV  in  GR/Mtv-2-  mice,  two 
proteins from the env gene, gp52 and gp36, and two proteins from the gag gene, p27 
and p l0, were used as tracer antigens in the radioimmunoassay (RIA). 714  MOUSE  MAMMARY  TUMOR  VIRUS  INDUCTION  GENES 
In Fig.  1 the results of competition assays for each of these viral proteins are shown. 
Comparison of the reactivity of tissue extracts with the reactivity of standard purified 
proteins  of  a  known  concentration  allowed  calculations  of  the  amounts  of  viral 
proteins  in  tissue extracts.  Purified  disrupted  MMTV  also served as standard  com- 
peting antigen.  In extracts of mammary glands of lactating GR mice, high amounts 
of each of the viral proteins were detected,  in the order of magnitude of 10 ~g viral 
protein per mg total protein. 
Extracts from lactating GR/Mtv-2- mice did compete in the RIA for the MMTV 
gag proteins p27 and p 10 at concentrations ranging from 200 to 2,000 ng viral protein 
per mg. The same extracts however did not react in the RIA for the env proteins gp52 
and gp36. Up till a total protein concentration of 10 mg/ml, no inhibition was found. 
Apparently,  the  genome of MMTV  was  incompletely  expressed  in  the  mammary 
glands of the GR/Mtv-2- strain.  Levels of the gag proteins were relatively high but 
essentially no env proteins were detected.  As a  rule, env and gag proteins are found 
in  concordant  amounts,  e.g.  in  the  C3Hf  strain  (12).  Results  of  a  number  of 
competition  RIA's in  individual  GR/Mtv-2-  mice  as  well  as  in  mice  from  other 
strains  are  summarized  in  Table  I.  It  shows  that  essentially  all  GR/Mtv-2-  mice 
tested were positive for MMTV p27 expression, already at the first lactation. 
To study the genetic  transmission of the MMTV  gag expression, an appropriate 
background strain had to be chosen. In a previous study we have shown that normal 
lactating mammary glands of several low mammary tumor strains, e.g. C57BL, 020 
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FIG.  1.  Competition  radioimmunoassay for individual  MMTV  structural  proteins gp52,  gp36, 
p27, and pl0.  (O)  Standard purified protein;  (0)  disrupted  MMTV;  (A)  extracts of mammary 
glands from GR mice; (A) extracts of mammary glands from GR/Mtv-2- mice. R.  NUSSE, J.  DE  MOES,  J.  HILKENS,  AND  R.  VAN  NIE 
TABLE  I 
Amounts of MMTV Viral Proteins in Extracts of Mammary Glands of Several Strains of Mice 
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Strain  Lactation 
Number of mice positive/tested 
gp52  ~"v  gp36  env  p27  g~g  pl0  gag 
GR/Mtv-2-  First  0/25  0/4  25/25 (210-1,800)  4/4 (20-800) 
Fourth  6/6 
BALB/c  First  0/6 
Fourth  0/16 
(GR/Mtv-2- X BALB/c)FI  First  0/13  13/13 (350-1,600) 
Fourth  0/12  12/12 
BALB/cfGR/Mtv-2-  Fourth  0/11  2/11  (2-10) 
GR  First  12/12 (10,000)  12/12 (10,000)  4/4 
Range  of amounts  of viral  proteins  is  given  between  parentheses  in  nanograms of viral  protein  per 
milligrams of tissue protein. 
TABLE  II 
Backcross Analysis of the Genetic Transmission of MMTV p27 Expression in 
Mammary Glands of GR/Mtv-2- Mice 
Backcross  I: (BALB/c ×  BALB/c GR/Mtv-2-) 
MMTV p27 expression 
Positive  Negative 
Es-3  42  40 
a/a  0  36 
a/B  42  4 
TABLE  III 
Progeny Testing of MMTV p27 Expression in GR/Mtv-2- Mice 
Backcross  II: (BALB/c X BALB/c GR/Mtv-2-) BALB/c 
Daughters from positive BCI mothers 
MMTV p27 expression 
Positive  Negative 
Es-3  36  43 
a/a  2  43 
a/B  34  0 
Daughters from negative BCI mothers 
MMTV p27 expression 
Positive  Negative 
Es-3  0  43 
a/a  0  41 
a/B  0  2 716  MOUSE  MAMMARY  TUMOR  VIRUS  INDUCTION  GENES 
and BALB/c do not contain detectable levels of MMTV proteins gp52 and p27 (12). 
Data on BALB/c mice are also given in Table I. In a cross of the GR/Mtv-2- strain 
with the BALB/c, the MMTV p27 expression behaved as a  fully dominant  feature, 
since  all  F1  hybrid  daughters  were  positive,  in  levels  comparable  to  those  in  the 
GR/Mtv-2- strain. 
Extrachromosomal  influences  are  known  to  interfere  sometimes considerably  in 
studies on genetic transmission of MMTV expression.  Especially the BALB/c strain 
is  extraordinary  sensitive  for replication  of exogenously  transmitted  MMTV  (21). 
Moreover, in the milk of GR/Mtv-2- mice MMTV antigens can be detected albeit at 
low levels ranging from 20 to  100 ng per mg. (A. Verstraeten.  Personal communica- 
tion.) It can be argued therefore that in crosses with GR/Mtv-2- mice as mothers, the 
milk transmitted MMTV rather than chromosomal inherited genes could give rise to 
virus expression in  the progeny. This was tested by fosternursing newborn  BALB/c 
mice to GR/Mtv-2- mothers and assaying the mammary glands for the presence of 
viral antigens. Except for two cases of very low amounts of p27 at late lactations, the 
fosternursed BALB/c mice did not show significant levels of virus expression. There- 
fore,  the  BALB/c  strain  was  regarded  as  an  appropriate  strain  for  the  mating 
experiments  to  study  the  genetic  transmission  of MMTV  p27  in  the  GR/Mtv-2- 
strain. 
Backcross Analysis of the  MMTV p27 Expression in  GR/Mtv-2-  Mice.  In  the  first 
backcross population MMTV p27 was measured in extracts of the mammary glands. 
Animals were scored as positive when the mammary gland contained more than 200 
ng viral proteins per mg tissue protein and as negative when none or very little (0.5- 
1 ng) viral protein per milligram tissue protein was detected. Intermediate levels were 
not found in any of the backcross mice. In Table II it is shown that the segregation of 
animals positive or negative  for p27  was very close to 50%  (~  =  0.04,  P  =  0.841), 
indicating  that  a  single  dominant  gene  governed  the  virus  expression.  The  same 
backcross animals were assayed for a number of segregating chromosomal markers. A 
close  linkage  of the  p27  expression  was  observed  with  the  Es-3  locus,  located  on 
chromosome 11. The Es-3 genotype, a/a or a/B, segregated itself as one gene (X  2 1.22, 
P 0.269) and only 4 recombinants between Es-3 and the gene for p27 expression were 
scored in 82 animals (X  2 66.78, 5% recombination). 
The one-gene model was further tested  in  a  second  backcross.  Female BCI mice 
were mated to BALB/c males and offspring daughters were also tested at the second 
lactation  for  p27  reactivity  in  the  mammary glands  Table  (III).  Daughters  from 
negative BCI  mothers were again  negative for viral antigens,  whereas  the progeny 
from positive BCI mothers again segregated very close to 50%  (X  2 0.62,  P  0.431),  as 
predicted by a single gene control. Also the linkage to the Es-3 locus persisted in the 
second backcross with a total of 2/79 (3%) recombinants. Levels of p27 expression in 
the backcross mice stayed within the same range as in the GR/Mtv-2- mice, indicating 
that virus expression was not restricted. Thus, also by progeny testing, the expression 
of MMTV  gag  proteins  in  the  GR/Mtv-2-  strain  could  be  demonstrated  to  be 
governed by a  single  dominant  gene,  located on chromosome  11,  close to the  Es-3 
lOCUS. 
Discussion 
The gene for expression of MMTV  gag proteins  in  the GR/Mtv-2- strain  is the 
third MMTV  induction  gene that is identified  in the mouse genome. Mtv-1, a  gene R.  NUSSE, J.  DE  MOES, J.  HILKENS, AND R.  VAN  NIE  717 
for moderate levels of MMTV proteins in the C3Hf and DBAf strains is located on 
chromosome 7 (22, 23). This gene is at least in the C3Hf strain also controlling the 
development of mammary tumors (22).  Mtv-2, the gene for high amounts of MMTV 
and  the early occurrence of mammary  tumors  in  the GR  strain  has  recently been 
mapped on chromosome  18.  (Van  Nie et al. Unpublished observations.) Molecular 
hybridization analysis, by reassociation kinetics as well as by hybridization to restric- 
tion enzyme fragments, has revealed that the Mtv-2 gene is identical to at least one 
proviral MMTV DNA copy (8, 24). Because of the absence of this MMTV proviral 
DNA in other strains, Mtv-2 has probably no allelic counterparts. 
Out  of the GR  strain,  a  congenic strain  has been created in our Institute.  This 
strain, the GR/Mtv-2- was developed by cross-intercross mating of a B 10-GR hybrid 
to  GR,  and  selecting  for  progeny mice  which  were  negative  for early  mammary 
tumors and high levels of virus antigens in the milk (11). Virus expression was tested 
by immunodiffusion, a relatively insensitive technique. However, with more sensitive 
radioimmunoassays,  viral  antigens  can  still  be  detected in  the  GR/Mtv-2-  strain. 
Amounts of antigens are a  10- to 100-fold lower than in the GR and characteristically, 
only MMTV  gag proteins are  detected. The levels are sufficiently high  to permit 
genetic analysis by crossing the strain  to the  virus  negative BALB/c strain,  and  a 
clear  1:1 segregation, indicative of a  single gene, is obtained. The gene is not linked 
with any of the other Mtv induction genes and is therefore called Mtv-3, located on 
chromosome 11. Since the GR/Mtv-2- strain is congenic to the GR strain except for 
the Mtv-2 locus, Mtv-3 is presumed to be present also in the GR, and will give rise to 
viral  antigens,  albeit  at  lower amounts  than  those  coded  for by the  Mtv-2  locus. 
Consequently, altogether two MMTV induction genes can be found in the GR when 
sensitive detection methods are employed, in accordance with studies by Heston et al. 
(6) and Bentvelzen et al. (10). 
Mtv-3 is not associated with early mammary tumor development. The spontaneous 
mammary  tumor  incidence  of the  GR/Mtv-2-  strain  in  our  colony  is  very  low. 
Therefore, the  results of Heston  & Parks who observed a  multifactorial pattern of 
inheritance of mammary tumors in the GR, cannot be ascribed to the Mtv-3 gene. 
Rather, extrachromosomal male transmission of MMTV can explain the high tumor 
incidence in segregating populations of crosses between GR and low mammary tumor 
incidence strains. 
An  unusual  feature of the  expression of the  Mtv-3  gene  is  the  absence of viral 
envelope glyeoproteins, in  the mammary gland  extracts, whereas core proteins are 
present in relatively high amounts. The partial expression of the MMTV genome in 
the  mammary  gland  might  be explained  by a  gene deletion.  Incomplete MMTV 
proviruses have been detected in the mouse genome with restriction enzyme analysis 
(25).  Alternatively,  the  recent  insight  into  the  mechanism  of RNA  and  protein 
synthesis may suggest that the deficiency in synthesis of envelope proteins is caused 
by a defective splicing mechanism. The 24S mRNA for envelope protein of retroviruses 
is derived from the 35S mRNA for core proteins by RNA splicing (26). Currently, the 
viral mRNA populations in mammary glands of GR/Mtv-2- mice are fractionated 
and  analyzed.  The  absence  of gp52  also  explains  the  lack  of a  humoral  immune 
response to MMTV  in the GR/Mtv-2-  strain  (27).  Production of similar  levels of 
viral core proteins, accompanied by envelope proteins such  as  in  the  C3Hf strain 
usually elicits antibodies which are directed against the envelope proteins (28). 718  MOUSE  MAMMARY TUMOR  VIRUS  INDUCTION GENES 
Thus far, three genes for MMTV  expression have been located on different sites of 
the mouse genome. Only the Mtv-1  locus has been shown  to have alleles in two, yet 
related, mouse strains, the C3Hf and  DBAf. The different chromosomal  location of 
Mtv-2 and Mtv-3 in the European GR strain supports the hypothesis that endogenous 
MMTV  proviruses are the result of relatively recent,  independent  germ lines infec- 
tions, rather than being evolved from ancient proviruses (29). 
Summary 
The  GR/Mtv-2-  mouse  strain  is congenic  to  the GR  strain  but  lacks the  Mtv-2 
gene for high amounts of mouse mammary  tumor virus (MMTV)  viriort particles in 
the milk and early mammary tumors. With a sensitive competition radioimmunoassay 
for individual viral proteins of MMTV,  substantial amounts of the gag proteins p27 
and  pl0  could  still be detected in  extracts of the mammary  glands of GR/Mtv-2- 
mice,  but  essentially no  viral  envelope  antigens.  The  genetic  transmission  of the 
MMTV  gag expression in the GR/Mtv-2-  strain was investigated. In a cross with the 
virus-negative BALB/c  strain,  the  MMTV  p27  expression behaved  as a  dominant 
feature. Double backcross analysis proved that the p27 expression was governed by a 
single gene located on chromosome  11, close to the Es-3 locus. The gene was thereby 
not  allelic to  any  of the  previously described MMTV  induction  genes,  Mtv-1  and 
Mtv-2, and is therefore called Mtv-3. It is concluded that the total MMTV  expression 
in  the  GR  strain  is under  control  of two  separate  loci, Mtv-2  on  chromosome  18, 
inducing high levels of complete virus particles and also early mammary tumors; and 
Mtv-3 on chromosome  11, coding for partial MMTV  expression. 
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